AARON DUPRE: Open Payments
NPI 1922706621 · SOUTHLAKE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,737 in 155 payments from 18 companies in 2025. Trend: 2023 $1,452 · 2024 $3,009 · 2025 $2,737
Food & beverage: $2,737
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $413 |
| Janssen Pharmaceuticals, Inc | 27 | $384 |
| Otsuka America Pharmaceutical, Inc. | 20 | $236 |
| E.R. Squibb & Sons, L.L.C. | 13 | $217 |
| Axsome Therapeutics, Inc. | 12 | $206 |
| Lundbeck LLC | 13 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $201 |
| Indivior Inc. | 9 | $177 |
| Supernus Pharmaceuticals, Inc. | 8 | $126 |
| Corium, LLC | 4 | $125 |
Products named: VRAYLAR, REXULTI, INVEGA SUSTENNA, COBENFY, Auvelity, CAPLYTA, SUBLOCADE, SPRAVATO.
Industry payments across TX — which companies pay providers there.
